News

Endovascular Today13h

RenovoRx Updates Pivotal TIGeR-PaC Trial of Pancreatic Cancer Treatment

RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first ...
Endovascular Today13h

FDA Issues Not-Approvable Letter for enVVeno’s VenoValve for CVI

August 20, 2025—enVVeno Medical Corporation announced that it has received a not-approvable letter from the FDA in response to its premarket app ...
Endovascular Today19h

Cook’s Advance Evero 18 Everolimus-Coated Balloon IDE Study Plan Approved by FDA

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...